Skip to main content
SINGULAR HEALTH GROUP LTD logo

SINGULAR HEALTH GROUP LTD — Investor Relations & Filings

Ticker · SHG ISIN · AU0000129892 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 364 across all filing types
Latest filing 2021-06-23 Regulatory Filings
Country AU Australia
Listing ASX SHG

About SINGULAR HEALTH GROUP LTD

https://singular.health/

Singular Health Group Ltd specializes in the development and commercialization of medical imaging software designed to enhance personalized healthcare. The company’s primary offering, the 3Dicom software suite, employs proprietary volume rendering technology to transform standard 2D DICOM files, such as CT and MRI scans, into immersive 3D visualizations. This platform supports surgical planning, remote clinical collaboration, and patient education by providing interactive anatomical models. Singular Health integrates artificial intelligence to automate image segmentation and diagnostic workflows, facilitating more precise clinical outcomes. Through its 'Scan to Surgery' initiative, the company bridges the gap between diagnostic imaging and physical intervention using virtual reality and 3D printing. Its solutions target medical practitioners, dental professionals, and healthcare institutions globally.

Recent filings

Filing Released Lang Actions
SHG launches innovative Medical File Transfer Protocol 3 pages 249.2KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 24 June 2021 from Singular Health Group Ltd. It describes the launch of a new technology product, the Medical File Transfer Protocol (MFTP), which is a blockchain-based method for transferring medical diagnostic images securely. The content focuses on the product features, benefits, and quotes from company executives and a medical professional. There are no financial statements, regulatory certifications, voting results, or management changes discussed. The document is a corporate announcement about a new technology product and its implications, not a financial report, earnings release, or regulatory filing. Therefore, it fits best under the category of a general regulatory announcement or corporate update that does not fit other specific categories, which corresponds to Regulatory Filings (RNS). The document length is 6935 characters, which is sufficient for a detailed announcement but does not contain financial data or report content to classify as an Annual Report, Interim Report, or Earnings Release.
2021-06-23 English
Restricted Securities to be Released from Escrow 1
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 22 June 2021 from Singular Health Group Ltd regarding the release of restricted securities from escrow. It mentions the number of shares to be released and the application to ASX for quotation of these shares. The content is a brief regulatory announcement about share escrow release and does not contain financial statements, management discussion, or detailed report data. The document length is short (901 characters), and it is clearly an announcement rather than a full report. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2021-06-21 English
Investor Presentation 20 pages 11.1MB
Regulatory Filings
2021-06-16 English
Restricted Securities to be Released from Escrow 1
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 17 June 2021 regarding the release of restricted securities from escrow. It mentions compliance with ASX Listing Rules and the release and quotation of shares. The content is a brief announcement about a capital structure event (release of shares from escrow) rather than a detailed financial report or presentation. The document length is short (902 characters), and it does not contain financial statements or detailed analysis. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2021-06-16 English
Appendix 2A - release of restricted securities from escrow 15 pages 338.5KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 2A Application for quotation of +securities' and is structured as a form for applying for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed questions about the entity, the type of securities, and the circumstances of the quotation application. The document is a regulatory announcement related to securities quotation rather than a financial report or earnings release. It is not an annual report, audit report, earnings release, or any form of financial statement. It is also not a management or board change announcement, nor a voting result or dividend notice. The document is a formal regulatory filing to the ASX for the purpose of listing securities, which fits the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit into more specific categories. The document length is 15,000 characters, indicating it is a full announcement, not a brief notice or report publication announcement. Therefore, the best classification is Regulatory Filings (RNS).
2021-06-02 English
Appendix 2A - release of restricted securities from escrow 15 pages 338.9KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 2A' and is an 'Application for quotation of securities' submitted to the ASX (Australian Securities Exchange). It includes detailed information about the entity, the type of securities to be quoted, and compliance with ASX Listing Rules. The document is a formal application related to the listing or quotation of securities on the exchange, not a financial report, earnings release, or management discussion. It is not an announcement of voting results, nor a report on board changes or legal proceedings. It is a regulatory filing specific to securities quotation under ASX rules, which fits best under the category of Regulatory Filings (RNS) as it does not match any other more specific category and is a compliance document submitted to a regulator.
2021-05-30 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.